Last reviewed · How we verify
NCT05240560
Proof of Concept Study Evaluating BP1.3656 in Patients With Fatigue Following Ischemic Stroke
Phase 2 trial testing BP1.3656 in Fatigue in 5 participants. Terminated before completion.
8 February 2024
Quick facts
| Lead sponsor | Bioprojet |
|---|---|
| Phase | Phase 2 |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 5 |
| Start date | 20 January 2023 |
| Primary completion | 8 February 2024 |
| Estimated completion | 8 February 2024 |
| Sites | 2 locations across France, Switzerland |
Drugs / interventions tested
- BP1.3656 — full drug profile →
Conditions studied
- Fatigue — all drugs for Fatigue →
Sponsor
Bioprojet — full company profile →
Who can join
18 and older, any sex, with Fatigue. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Multicenter, randomized, double blind, parallel-group, placebo-controlled proof of concept study evaluating efficacy and safety of BP1.3656 in patients with fatigue following ischemic stroke.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05240560
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of BP1.3656
Trials testing the same drug.
- NCT04727086 — Role of BP1.3656 on Alcohol Responses · Phase 2 · completed
Other recruiting trials for Fatigue
Currently open trials in the same condition.
- NCT07073963 — Virtual Patient Groups for Sarcoidosis Associated Fatigue · NA · recruiting
- NCT07421960 — Investigation of the Relationship Between Periodontitis and Sleep Quality · recruiting
- NCT07071324 — CF Wellness Program · NA · recruiting
- NCT07386691 — Comparing Effect of Intradialytic Aerobic Exercise Versus Incentive Spirometer on Fatigue and Sleep Quality Among Hemodi · NA · active not recruiting
- NCT06819254 — Pilot Study of Fisetin to Improve Fatigue Among Older Adult Cancer Survivors · Phase 4 · recruiting
Other Bioprojet trials
Trials by the same sponsor.
- NCT05118906 — Pilot Study on BP1.4979 Effect on Binge Eating Disorders · Phase 2 · completed
- NCT03345953 — Clinical Trial Assessing the Efficacy and Safety of BP1.4979 in Restless Legs Syndrome · Phase 2 · terminated
- NCT03424824 — Randomized Clinical Trial Evaluating BP1.3656 Versus Placebo For Alcohol Use Disorder Treatment · Phase 2 · completed
- NCT03152123 — Determination the Abuse Potential of Pitolisant in Healthy, Non-Dependent Recreational Stimulant Users · Phase 1 · completed
- NCT02611687 — Efficacy and Safety of Pitolisant in Pediatric Narcoleptic Patients With or Without Cataplexy, Double-blind Study Follow · Phase 3 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05240560 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Bioprojet
- Last refreshed: 9 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05240560.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing